CAS 1001264-89-6: GDC 0068
Formula:C24H32ClN5O2
InChI:InChI=1S/C24H32ClN5O2/c1-15(2)26-13-19(17-4-6-18(25)7-5-17)24(32)30-10-8-29(9-11-30)23-21-16(3)12-20(31)22(21)27-14-28-23/h4-7,14-16,19-20,26,31H,8-13H2,1-3H3/t16-,19-,20-/m1/s1
InChI key:InChIKey=GRZXWCHAXNAUHY-NSISKUIASA-N
SMILES:C[C@H]1C2=C(N=CN=C2[C@H](O)C1)N3CCN(C([C@H](CNC(C)C)C4=CC=C(Cl)C=C4)=O)CC3
Synonyms:- 1-Propanone, 2-(4-chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-, (2S)-
- Gdc-0068
- Ipatasertib
- Rg 7440
- Rg7440
- (2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone
- (2s)-2-(4-chlorophenyl)-1-(4-((5r,7r)-6,7-dihydro-7-hydroxy-5-methyl-5h-cyclopentapyrimidin-4-yl)-1-piperazinyl)-3-((1-methylethyl)amino)-1-propanone
Sort by
Found 6 products.
Ipatasertib
CAS:Ipatasertib (GDC-0068) is a selective, ATP-competitive pan-Akt inhibitor that can lead to p53-independent PUMA activation.Cost-effective and quality-assured.Formula:C24H32ClN5O2Purity:98.28% - 99.21%Color and Shape:SolidMolecular weight:458Ipatasertib
CAS:Ipatasertib is a drug that belongs to the class of inhibitors of the ATP-binding cassette (ABC) transporter protein P-glycoprotein. It prevents the efflux of drugs from cancer cells, thereby increasing their concentration in tumor tissue. Ipatasertib has been shown to be effective against eye disorders with minimal toxicity in vitro and in vivo. The drug binds to the bicylcic heterocycle as a result of its activity as an ATPase inhibitor and blocks tumor growth by inhibiting receptor activity.Formula:C24H32ClN5O2Purity:Min. 95%Molecular weight:458 g/mol(2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone
CAS:Applications (2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone is a highly selective AKT inhibitor targeting Akt1, Akt2 and Akt3. Studies have shown its use in combination with vemurafenib (V118500), have demonstrated therapeutic value in the treatment of hyperproliferative disorders such as cancer. References Jie, L., et al.: Clin. Cancer. Res., 10, 1078 (2013);Formula:C24H32ClN5O2Color and Shape:NeatMolecular weight:458.0Ipatasertib-D7
CAS:Controlled ProductFormula:C24H25D7ClN5O2Color and Shape:NeatMolecular weight:465.021-Propanone, 2-(4-chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-, (2S)-
CAS:Formula:C24H32ClN5O2Purity:98%Color and Shape:SolidMolecular weight:457.99618000000004
![(2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb%2FC377870.jpg&w=3840&q=75)
